John J Haddad. The Irreversible Inhibition of the MAPK
Pathway Downregulates LPS-augmented Release of Interleukin-Related Inflammatory Cytokines (IL-1β, IL-6): Immune Surveillance Unraveling IκB-α/NF-κB Phosphorylation State-independent Mechanism
.
. 2015; 3(5):133-138. doi: 10.12691/AJMBR-3-5-3
electrophoresis, ELISA, IκB-α, IL-1β, IL-6, inflammation, MAPKs, NF-κB
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit
[1] | Haddad, J.J., and L.B. Hanbali, 2014. Hypoxia upregulates MAPKp38/MAPKERK phosphorylation in vitro: Neuroimmunological differential time-dependent expression of MAPKs. Protein Pept. Lett., 21: 444-451. |
|
[2] | Haddad, J.J., 2011. A redox microenvironment is essential for MAPK-dependent secretion of pro-inflammatory cytokines: Modulation by glutathione (GSH/GSSG) biosynthesis and equilibrium in the alveolar epithelium. Cell. Immunol., 270: 53-61. |
|
[3] | Haddad, J.J., 2013. On the cellular and molecular regulatory transcriptional mechanisms and responsive putative pathways to inflammatory oxidative stress revisited: Current immunological breakthroughs and views at a glance. Antiinflamm. Antiallergy Agents Med. Chem., 12: 141-157. |
|
[4] | Fernandez-Bustamante, A., Agazio, A., Wilson, P., Elkins, N., Domaleski, L., He, Q., Baer, K.A., Moss, A.F., Wischmeyer, P.E., and J.E. Repine, 2015. Brief glutamine pretreatment increases alveolar macrophage CD163/heme oxygenase-1/p38-MAPK dephosphorylation pathway and decreases capillary damage but not neutrophil recruitment in IL-1/LPS-insufflated rats. PLoS One, 10: e0130764. |
|
[5] | Haddad, J.J., and N.E. Abdel-Karim, 2011. NF-κB cellular and molecular regulatory mechanisms and pathways: Therapeutic pattern or pseudoregulation? Cell. Immunol., 271: 5-14. |
|
[6] | Haddad, JJ., and H.L. Harb, 2005. L-γ-Glutamyl-L-cysteinyl-glycine (glutathione; GSH) and GSH-related enzymes in the regulation of pro- and anti-inflammatory cytokines: A signaling transcriptional scenario for redox(y) immunologic sensor(s)? Mol. Immunol., 42: 987-1014. |
|
[7] | Haddad, J.J., 2004. Hypoxia and the regulation of mitogen-activated protein kinases: gene transcription and the assessment of potential pharmacologic therapeutic interventions. Int. Immunopharmacol., 4: 1249-1285. |
|
[8] | Haddad, J.J., 2002. Cytokines and related receptor-mediated signaling pathways. Biochem. Biophys. Res. Commun., 297: 700-713. |
|
[9] | Fehr, S., Unger, A., Schaeffeler, E., Herrmann, S., Laufer, S., Schwab, M., and W. Albrecht, 2015. Impact of p38 MAP kinase inhibitors on LPS-induced release of TNF-α in whole blood and primary cells from different species. Cell. Physiol. Biochem., 36: 2237-2249. |
|
[10] | Lv, H., Zhu, C., Liao, Y., Gao, Y., Lu, G., Zhong, W., Zheng, Y., Chen, W., and X. Ci, 2015. Tenuigenin ameliorates acute lung injury by inhibiting NF-κB and MAPK signalling pathways. Respir. Physiol. Neurobiol., 216: 43-51. |
|
[11] | Khan, S., Shehzad, O., Cheng, M.S., Li, R.J., and Y.S. Kim, 2015. Pharmacological mechanism underlying anti-inflammatory properties of two structurally divergent coumarins through the inhibition of pro-inflammatory enzymes and cytokines. J. Inflamm. (Lond.), 12: 47. |
|
[12] | Chen, H., Jiang, Y.S., Sun, Y., and Y.C. Xiong, 2015. p38 and interleukin-1 beta pathway via toll-like receptor 4 contributed to the skin and muscle incision and retraction-induced allodynia. J. Surg. Res., 197: 339-347. |
|
[13] | Gupta, J., and A.R. Nebreda, 2015. Roles of p38α mitogen-activated protein kinase in mouse models of inflammatory diseases and cancer. FEBS J., 282: 1841-1857. |
|
[14] | Sabio, G., and R.J. Davis, 2014. TNF and MAP kinase signalling pathways. Semin. Immunol., 26: 237-245. |
|
[15] | Patterson, H., Nibbs, R., McInnes, I., and S. Siebert, 2014. Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases. Clin. Exp. Immunol., 176: 1-10. |
|
[16] | Peti, W., and R. Page, 2013. Molecular basis of MAP kinase regulation. Protein Sci., 22: 1698-1710. |
|
[17] | Ding, Y., Yang, H., Xiang, W., He, X., Liao, W., and Z. Yi, 2015. CD200R1 agonist attenuates LPS-induced inflammatory response in human renal proximal tubular epithelial cells by regulating TLR4-MyD88-TAK1-mediated NF-κB and MAPK pathway. Biochem. Biophys. Res. Commun., 460: 287-294. |
|